genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Anticancer Drug Candidate Inhibits Novel Alzheimer’s Disease Target to Protect Neurons
News
Gut Microbiome Can Suppress Food Allergies: Just Add “Good” Bacteria
News
Novel Test Reportedly Detects Liver Disease Years Before It Can Become…
News
Alzheimer’s Progression May Hinge on Newfound Amyloid-Tau Link
Bristol-Myers Squibb
BMS Selling Celgene’s Otezla to Address FTC “Concerns” on $74B Deal
Insights
Insights
Single Cell Writing May Unlock CRISPR’s Full Potential
Tech Exclusives
Turning Drug Delivery Inside Out
Insights
Sartorius Takes a Single-Use Approach to Derive Value from Biomanufacturing
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Tech Exclusives
Not If. When: Metabolomics’ Impact in Cancer Treatments May Be Just…
A-Lists
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
June 2019 Vol. 39 No. 6
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Anticancer Drug Candidate Inhibits Novel Alzheimer’s Disease Target to Protect Neurons
News
Gut Microbiome Can Suppress Food Allergies: Just Add “Good” Bacteria
Insights
Single Cell Writing May Unlock CRISPR’s Full Potential
Bristol-Myers Squibb
BMS Selling Celgene’s Otezla to Address FTC “Concerns” on $74B Deal
Magazine
All
Supplement
Tech Exclusives
Fighting the Dangerous Increase of Multidrug-Resistant Microbes
Tech Exclusives
The Microbiome: Here, There, and Everywhere
Commentary
New Vaccine Expected to Play Major Role in Battle against Malaria
Commentary
Lipidomics Enriches Multiomics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
A Web-Based Informatics Platform for PhysChem/ADME/Tox Property Predictions
GENcast
GENcast: Microbiome Research is More Than Just a Gut Reaction
Upcoming Webinars
Mind the Yap! Single-Cell Transcriptomes Reveal Drivers of Intestinal Regeneration
eBooks
Best Practices with an Agilent Parallel CE System
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Cancer
Lymphoma
Lymphoma
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lymphoma
Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse Large B-Cell Lymphoma
Lymphoma
Lymphoma Resistance Mechanism to Chemo Drug Identified
Lymphoma
Cancer Drug Developers GTx, Oncternal Plan Reverse Merger
Lymphoma
FDA Approves First Non-Chemo Combination Therapy for a Form of Leukemia
Lymphoma
Harbour BioMed to Develop Kelun-Biotech’s Cancer Immunotherapy Candidate A167
Lymphoma
Epizyme Halts Phase II Trial of Tazemetostat in DLBCL Cohorts, Continues...
Lymphoma
Aggressive Lymphoma Linked with JAK Inhibitor Use
Lymphoma
FDA Imposes Partial Clinical Hold on Epizyme Lead Candidate after Patient...
Lymphoma
MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO
Lymphoma
Kite, Pfizer to Assess Yescarta-Utomilumab Combination in Lymphoma
Lymphoma
Chimera Virus Constructed for Potential New Lymphoma Therapy
Lymphoma
Cancer Cell Therapy Developer Kite Pharma Finds $11.9B Buyer in Gilead
Lymphoma
Pacira Ends Production of DepoCyt
Lymphoma
BMS, Seattle Agree to Phase III HL Trial Combining Opdivo and...
Lymphoma
Debiopharm Pays $25M Upfront for ImmunoGen’s Phase II Stage ADC for...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
